ConductScience.org, home

Paper23174751

Personalized treatment of uveal melanoma.

Damato B and 1 other. Eye (Lond), 2013. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Personalized treatment of uveal melanoma. Papers, record 23174751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23174751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Personalized treatment of uveal melanoma.
PubMed
Journal
Eye (Lond)
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.98
iCite
Revised in PubMed
2025-01-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Damato BB
2Heimann HH

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Patient-Centered CareMajor topic
Uveal NeoplasmsMajor topic
Counseling
England
Family
Humans
Uveal Melanoma

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111642372Vitreoretinal surgery and endoresection in high posterior choroidal melanomas.Retina2001https://conductscience.org/library/papers/11642372PubMed
222042014Local resection of uveal melanoma.Dev Ophthalmol2012https://conductscience.org/library/papers/22042014PubMed
322744385Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.Eye (Lond)2012https://conductscience.org/library/papers/22744385PubMed
422042010Treatment selection for uveal melanoma.Dev Ophthalmol2012https://conductscience.org/library/papers/22042010PubMed
521658465Estimating prognosis for survival after treatment of choroidal melanoma.Prog Retin Eye Res2011https://conductscience.org/library/papers/21658465PubMed
616111578Proton beam radiotherapy of iris melanoma.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/16111578PubMed
716946742Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy.Eye (Lond)2007https://conductscience.org/library/papers/16946742PubMed
818653597Endoresection in high posterior choroidal melanomas: long-term outcome.Br J Ophthalmol2008https://conductscience.org/library/papers/18653597PubMed
922079972Differences in uveal melanomas between men and women from the British Isles.Eye (Lond)2012https://conductscience.org/library/papers/22079972PubMed
1022521086Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.Ophthalmology2012https://conductscience.org/library/papers/22521086PubMed
119602614Endoresection of choroidal melanoma.Br J Ophthalmol1998https://conductscience.org/library/papers/9602614PubMed
1216029800Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/16029800PubMed
1310070510Taping outpatient consultations: a survey of attitudes and responses of adult patients with ocular malignancy.Eye (Lond)1998https://conductscience.org/library/papers/10070510PubMed
1421746991Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type.Arch Ophthalmol2011https://conductscience.org/library/papers/21746991PubMed
1521029286Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma.Health Expect2011https://conductscience.org/library/papers/21029286PubMed
1615990248Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15990248PubMed
179544628Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases.Ophthalmology1998https://conductscience.org/library/papers/9544628PubMed
1822522723A nurse-led ocular oncology clinic in Liverpool: results of a 6-month trial.Eye (Lond)2012https://conductscience.org/library/papers/22522723PubMed
1918653590Choroidal melanoma endoresection, dandelions and allegory-based medicine.Br J Ophthalmol2008https://conductscience.org/library/papers/18653590PubMed
2015913907Local tumor control after 106Ru brachytherapy of choroidal melanoma.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15913907PubMed

See all 28 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
42303830GWAS meta-analysis provides new insights into uveal melanoma risk.Br J Cancer2026https://conductscience.org/library/papers/42303830PubMed
41632384Uveal melanoma survival prediction system: a multi-center database study.Int Ophthalmol2026https://conductscience.org/library/papers/41632384PubMed
41151907Clinical Applications of Artificial Intelligence in Uveal Melanoma.Anticancer Res2025https://conductscience.org/library/papers/41151907PubMed
40723158The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis.Cancers (Basel)2025https://conductscience.org/library/papers/40723158PubMed
40213305Surgical treatment of uveal melanoma: Exoresection versus endoresection.Taiwan J Ophthalmol2025https://conductscience.org/library/papers/40213305PubMed
39918656Artificial intelligence with ChatGPT 4: a large language model in support of ocular oncology cases.Int Ophthalmol2025https://conductscience.org/library/papers/39918656PubMed
39548476
Anxiety, depression and fear of cancer recurrence in uveal melanoma survivors and ophthalmologist/oncologist communication during survivorship in France - protocol of a prospective observational mixed-method study.
BMC Psychiatry2024https://conductscience.org/library/papers/39548476PubMed
38347180Local anaesthesia under sedation versus general anaesthesia for brachytherapy-treated patients with uveal melanoma: A patient-reported outcome study.Eye (Lond)2024https://conductscience.org/library/papers/38347180PubMed
37752341Prevalence, temporal course and risk factors for phantom eye symptoms in uveal melanoma.Eye (Lond)2024https://conductscience.org/library/papers/37752341PubMed
37174076Sensitivity and Specificity of Different Prognostic Systems in Guiding Surveillance for Metastases in Uveal Melanoma.Cancers (Basel)2023https://conductscience.org/library/papers/37174076PubMed
36672282Ocular Complications of Radiotherapy in Uveal Melanoma.Cancers (Basel)2023https://conductscience.org/library/papers/36672282PubMed
35941183Predictors of emotional distress in uveal melanoma survivors: a systematic review.Eye (Lond)2023https://conductscience.org/library/papers/35941183PubMed
35348598Vascular Lakes in Uveal Melanoma and Their Association With Outcome.Transl Vis Sci Technol2022https://conductscience.org/library/papers/35348598PubMed
34850324Fear of cancer recurrence and adverse cancer treatment outcomes: predicting 2- to 5-year fear of recurrence from post-treatment symptoms and functional problems in uveal melanoma survivors.J Cancer Surviv2023https://conductscience.org/library/papers/34850324PubMed
34453274Prediction of all-cause mortality from 24 month trajectories in patient-reported psychological, clinical and quality of life outcomes in uveal melanoma patients.J Behav Med2022https://conductscience.org/library/papers/34453274PubMed
34298647Poor Response to Checkpoint Immunotherapy in Uveal Melanoma Highlights the Persistent Need for Innovative Regional Therapy Approaches to Manage Liver Metastases.Cancers (Basel)2021https://conductscience.org/library/papers/34298647PubMed
34085131Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications.Insights Imaging2021https://conductscience.org/library/papers/34085131PubMed
34015800Two 11-Years Periods Statistics and Trends of Enucleation and Evisceration.J Craniofac Surg2021https://conductscience.org/library/papers/34015800PubMed
33871760Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors.J Cancer Surviv2022https://conductscience.org/library/papers/33871760PubMed
33066024
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma Cells.
Cancers (Basel)2020https://conductscience.org/library/papers/33066024PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23174751

GET https://conductscience.org/api/papers/v1/23174751/references?page=2